Frank Robert Busch

Person

Gales Ferry, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Processes and intermediates for preparing glycogen phosphorylase in...
- Patent number 6,696,574
- Issue date Feb 24, 2004
- Pfizer Inc.
- Mark T. Barrila
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-(indole-2-carbonyl)-b-alaninamide crystal forms
- Patent number 6,683,106
- Issue date Jan 27, 2004
- Pfizer Inc.
- Douglas J. M. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing growth hormone secretagogues
- Patent number 6,673,929
- Issue date Jan 6, 2004
- Pfizer Inc.
- Frank R. Busch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for preparing sodium-hydrogen exchanger type-1 inhibitors
- Patent number 6,627,643
- Issue date Sep 30, 2003
- Pfizer Inc.
- Frank R. Busch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Process for preparing growth hormone secretagogues
- Patent number 6,541,634
- Issue date Apr 1, 2003
- Pfizer Inc.
- Frank R. Busch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-pip...
- Patent number 6,245,765
- Issue date Jun 12, 2001
- Pfizer Inc.
- Frank R. Busch
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Ziprasidone formulations
- Patent number 6,150,366
- Issue date Nov 21, 2000
- Pfizer Inc.
- Daniel R. Arenson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-pip...
- Patent number 6,110,918
- Issue date Aug 29, 2000
- Pfizer Inc.
- Frank R. Busch
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for steroidal peracyl glycosides
- Patent number 5,606,041
- Issue date Feb 25, 1997
- Pfizer Inc.
- Frank R. Busch
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for making steroidal peracyl glycosides
- Patent number 5,530,107
- Issue date Jun 25, 1996
- Pfizer Inc.
- Douglas J. M. Allan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Preparation of beta-ketoesters useful in preparing quinolone antibi...
- Patent number 5,380,860
- Issue date Jan 10, 1995
- Pfizer Inc.
- Frank R. Busch
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing aryl piperazinyl-heterocyclic compounds with...
- Patent number 5,338,846
- Issue date Aug 16, 1994
- Pfizer Inc.
- Frank R. Busch
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-eth...
- Patent number 5,312,925
- Issue date May 17, 1994
- Pfizer Inc.
- Douglas J. M. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Processes for (3S,4R)-3-[1(R)-t-butyl-dimethylsilyloxy)-ethyl]-4-[1...
- Patent number 5,075,439
- Issue date Dec 24, 1991
- Pfizer Inc.
- Frank R. Busch
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Preparation of High Purity Substituted Quinoxalines
- Publication number 20080275051
- Publication date Nov 6, 2008
- Frank R. Busch
- C07 - ORGANIC CHEMISTRY
Information Patent Application
VARENICLINE STANDARDS AND IMPURITY CONTROLS
- Publication number 20070224690
- Publication date Sep 27, 2007
- Pfizer Inc.
- Frank R. Busch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-(indole-2-carbonyl)-b-alaninamide crystal forms
- Publication number 20040152758
- Publication date Aug 5, 2004
- Pfizer Inc.
- Douglas J. M. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Ziprasidone composition and synthetic controls
- Publication number 20040048876
- Publication date Mar 11, 2004
- Pfizer Inc.
- Frank R. Busch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-(indole-2-carbonyl)-b-alaninamide crystal forms
- Publication number 20030195243
- Publication date Oct 16, 2003
- Pfizer Inc.
- Douglas J. M. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Processes and intermediates for preparing glycogen phosphorylase in...
- Publication number 20030187051
- Publication date Oct 2, 2003
- Pfizer Inc.
- Mark T. Barrila
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Process for preparing growth hormone secretagogues
- Publication number 20030158414
- Publication date Aug 21, 2003
- Frank R Busch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR PREPARING SODIUM-HYDROGEN EXCHANGER TYPE-1 INHIBITORS
- Publication number 20030119873
- Publication date Jun 26, 2003
- Pfizer Inc.
- Frank R. Busch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of growth hormone secretagogues to treat systemic lupus erythem...
- Publication number 20020013320
- Publication date Jan 31, 2002
- Frank Robert Busch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination of growth hormone secretagogues and antidepressants
- Publication number 20020002137
- Publication date Jan 3, 2002
- Frank Robert Busch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Process for preparing growth hormone secretagogues
- Publication number 20020002283
- Publication date Jan 3, 2002
- Frank R Busch
- C07 - ORGANIC CHEMISTRY

Frank Robert Busch

Person

Patents Grantslast 30 patents

Processes and intermediates for preparing glycogen phosphorylase in...

N-(indole-2-carbonyl)-b-alaninamide crystal forms

Process for preparing growth hormone secretagogues

Methods for preparing sodium-hydrogen exchanger type-1 inhibitors

Process for preparing growth hormone secretagogues

Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-pip...

Ziprasidone formulations

Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-pip...

Process for steroidal peracyl glycosides

Method for making steroidal peracyl glycosides

Preparation of beta-ketoesters useful in preparing quinolone antibi...

Process for preparing aryl piperazinyl-heterocyclic compounds with...

Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-eth...

Processes for (3S,4R)-3-[1(R)-t-butyl-dimethylsilyloxy)-ethyl]-4-[1...

Patents Applicationslast 30 patents

Preparation of High Purity Substituted Quinoxalines

VARENICLINE STANDARDS AND IMPURITY CONTROLS

N-(indole-2-carbonyl)-b-alaninamide crystal forms

Ziprasidone composition and synthetic controls

N-(indole-2-carbonyl)-b-alaninamide crystal forms

Processes and intermediates for preparing glycogen phosphorylase in...

Process for preparing growth hormone secretagogues

METHODS FOR PREPARING SODIUM-HYDROGEN EXCHANGER TYPE-1 INHIBITORS

Use of growth hormone secretagogues to treat systemic lupus erythem...

Combination of growth hormone secretagogues and antidepressants

Process for preparing growth hormone secretagogues